The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis
An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its complications, in particular, a high risk of cardiov...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
State Scientific Center of Dermatovenereology and Cosmetology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02e308f43c6744709c9428eeb4e7f89a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:02e308f43c6744709c9428eeb4e7f89a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:02e308f43c6744709c9428eeb4e7f89a2021-12-01T22:16:30ZThe role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis0042-46092313-629410.25208/vdv1206https://doaj.org/article/02e308f43c6744709c9428eeb4e7f89a2021-04-01T00:00:00Zhttps://vestnikdv.ru/jour/article/viewFile/1206/1179https://doaj.org/toc/0042-4609https://doaj.org/toc/2313-6294An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its complications, in particular, a high risk of cardiovascular complications. For PA, dyslipidemias are most characteristic, manifested by an increased level of low and very low density lipoproteins, triglycerides and total cholesterol, which correlates with the activity of the disease. The literature review studied the pathogenesis of dyslipidemias and vascular wall lesions in psoriatic arthritis, analyzed the literature on cardiovascular complications and mortality among patients with PA, studied the issues of total cardiovascular risk, presented the results of numerous clinical studies that allow PA to be considered a disease associated with increased the risk of cardiovascular complications. Considering the role of proinflammatory cytokines in the pathogenesis of psoriatic arthritis, early detection of endothelial lesions represents the most promising direction in the prevention of cardiovascular diseases, which are the main cause of mortality in this group of patients.Zarema R. KhismatullinaKsenia M. KoreshkovaState Scientific Center of Dermatovenereology and Cosmetologyarticlepsoriatic arthritisdyslipidemiasatherosclerosiscardiovascular complicationsDermatologyRL1-803RUVestnik Dermatologii i Venerologii, Vol 97, Iss 2, Pp 16-22 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
psoriatic arthritis dyslipidemias atherosclerosis cardiovascular complications Dermatology RL1-803 |
spellingShingle |
psoriatic arthritis dyslipidemias atherosclerosis cardiovascular complications Dermatology RL1-803 Zarema R. Khismatullina Ksenia M. Koreshkova The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
description |
An increased risk of cardiovascular events has now been identified in patients with psoriatic arthritis. The chronic immune-mediated inflammation underlying psoriatic arthritis (PA) leads to the development of dyslipidemia, atherosclerosis and its complications, in particular, a high risk of cardiovascular complications. For PA, dyslipidemias are most characteristic, manifested by an increased level of low and very low density lipoproteins, triglycerides and total cholesterol, which correlates with the activity of the disease. The literature review studied the pathogenesis of dyslipidemias and vascular wall lesions in psoriatic arthritis, analyzed the literature on cardiovascular complications and mortality among patients with PA, studied the issues of total cardiovascular risk, presented the results of numerous clinical studies that allow PA to be considered a disease associated with increased the risk of cardiovascular complications. Considering the role of proinflammatory cytokines in the pathogenesis of psoriatic arthritis, early detection of endothelial lesions represents the most promising direction in the prevention of cardiovascular diseases, which are the main cause of mortality in this group of patients. |
format |
article |
author |
Zarema R. Khismatullina Ksenia M. Koreshkova |
author_facet |
Zarema R. Khismatullina Ksenia M. Koreshkova |
author_sort |
Zarema R. Khismatullina |
title |
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
title_short |
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
title_full |
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
title_fullStr |
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
title_full_unstemmed |
The role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
title_sort |
role of endothelial damage and dyslipidemia in the development of cardiovascular pathology in psoriatic arthritis |
publisher |
State Scientific Center of Dermatovenereology and Cosmetology |
publishDate |
2021 |
url |
https://doaj.org/article/02e308f43c6744709c9428eeb4e7f89a |
work_keys_str_mv |
AT zaremarkhismatullina theroleofendothelialdamageanddyslipidemiainthedevelopmentofcardiovascularpathologyinpsoriaticarthritis AT kseniamkoreshkova theroleofendothelialdamageanddyslipidemiainthedevelopmentofcardiovascularpathologyinpsoriaticarthritis AT zaremarkhismatullina roleofendothelialdamageanddyslipidemiainthedevelopmentofcardiovascularpathologyinpsoriaticarthritis AT kseniamkoreshkova roleofendothelialdamageanddyslipidemiainthedevelopmentofcardiovascularpathologyinpsoriaticarthritis |
_version_ |
1718404140930957312 |